Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Curis Inc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
CRIS
Nasdaq
2836
https://www.curis.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Curis Inc
Curis, Inc. (NASDAQ:CRIS) Q4 2023 Earnings Call Transcript
- Feb 9th, 2024 3:10 pm
Curis Provides Fourth Quarter 2023 Business Update
- Feb 8th, 2024 1:00 pm
Curis to Release Fourth Quarter 2023 Financial Results and Hold Conference Call on February 8, 2024
- Feb 1st, 2024 1:00 pm
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Jan 5th, 2024 1:00 pm
Curis, Inc. (NASDAQ:CRIS) Surges 54% Yet Its Low P/S Is No Reason For Excitement
- Dec 18th, 2023 12:43 pm
Curis Announces Initial Combination Study Data from its TakeAim Lymphoma Study
- Dec 12th, 2023 1:00 pm
Curis Presented Clinical Data from the TakeAim Leukemia Study at the 2023 ASH Conference
- Dec 11th, 2023 1:00 pm
Curis Announces Three Presentations at ASH
- Dec 6th, 2023 1:00 pm
Curis Enters into Agreement for Emavusertib / Pembrolizumab Combination Study in Melanoma
- Dec 5th, 2023 1:00 pm
Curis, Inc. (NASDAQ:CRIS) Q3 2023 Earnings Call Transcript
- Nov 3rd, 2023 2:26 pm
Curis Inc (CRIS) Reports Q3 2023 Financial Results: Net Loss Decreases Year-Over-Year
- Nov 3rd, 2023 10:03 am
Curis Provides Third Quarter 2023 Business Update
- Nov 2nd, 2023 12:00 pm
2seventy bio, Inc. (TSVT) Expected to Beat Earnings Estimates: Should You Buy?
- Oct 30th, 2023 2:00 pm
Curis to Release Third Quarter 2023 Financial Results and Hold Conference Call on November 2, 2023
- Oct 26th, 2023 12:30 pm
We're Hopeful That Curis (NASDAQ:CRIS) Will Use Its Cash Wisely
- Oct 23rd, 2023 10:07 am
Pharming Group N.V. Sponsored ADR (PHAR) Soars 14.7%: Is Further Upside Left in the Stock?
- Sep 22nd, 2023 7:15 am
Curis Announces Date for the 2nd Symposium on IRAK4 in Cancer
- Sep 12th, 2023 12:00 pm
Curis to Present at Upcoming Healthcare Conferences in September
- Sep 6th, 2023 12:13 pm
Curis, Inc. (NASDAQ:CRIS) Q2 2023 Earnings Call Transcript
- Aug 5th, 2023 9:57 am
Curis (CRIS) Reports Q2 Loss, Misses Revenue Estimates
- Aug 3rd, 2023 9:45 pm
Scroll